Top

Reactions Weekly

Published in:

01-06-2022 | Liver Transplantation | Case report

Tigecycline

Drug-induced cholestatic liver injury following off-label use: case report

Published in: Reactions Weekly | Issue 1/2022

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Shi X, et al. A case report of drug-induced liver injury after tigecycline administration: histopathological evidence and a probable causality grading as assessed by the updated RUCAM diagnostic scale. BMC Infectious Diseases 22: No. 1, Apr 2022. Available from: URL: http://doi.org/10.1186/s12879-022-07258-w

Title: Tigecycline
Drug-induced cholestatic liver injury following off-label use: case report
Publication date: 01-06-2022
Publisher: Springer International Publishing
Keywords: Liver Transplantation
Hepatitis B
Expectoration
Meropenem
Carbapenem Antibiotic
Nosocomial Pneumonia
Liver Transplantation
Liver Transplantation
Liver Transplantation
Liver Transplantation
Tigecycline
Tacrolimus
Published in: Reactions Weekly / Issue 1/2022
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-022-16807-5

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Tigecycline

Drug-induced cholestatic liver injury following off-label use: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2022

Denosumab

Dupilumab/montelukast

Azathioprine/triamcinolone

Fentanyl

Ibrutinib

COVID-19 vaccine-induced VITT/TSS in Malaysia